These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19090969)

  • 1. Putative growth characteristics of micrometastatic breast cancer.
    Chambers AF; Goss PE
    Breast Cancer Res; 2008; 10(6):114. PubMed ID: 19090969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour dormancy: findings and hypotheses from clinical research on breast cancer.
    Demicheli R
    Semin Cancer Biol; 2001 Aug; 11(4):297-306. PubMed ID: 11513565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis.
    Allan AL; Vantyghem SA; Tuck AB; Chambers AF
    Breast Dis; 2006-2007; 26():87-98. PubMed ID: 17473368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploiting Mouse Models to Recapitulate Clinical Tumor Dormancy and Recurrence in Breast Cancer.
    Gu Y; Bui T; Muller WJ
    Endocrinology; 2022 Jun; 163(6):. PubMed ID: 35560214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms driving local breast cancer recurrence in a model of breast-conserving surgery.
    Smith MJ; Culhane AC; Killeen S; Kelly MA; Wang JH; Cotter TG; Redmond HP
    Ann Surg Oncol; 2008 Oct; 15(10):2954-64. PubMed ID: 18622646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proposal for a new model of breast cancer metastatic development.
    Demicheli R; Retsky MW; Swartzendruber DE; Bonadonna G
    Ann Oncol; 1997 Nov; 8(11):1075-80. PubMed ID: 9426326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How can we integrate the biology of breast cancer cell dormancy into clinical practice?
    Elkholi IE; Rose AAN; Aguirre-Ghiso JA; Côté JF
    Cancer Cell; 2024 Jul; 42(7):1147-1151. PubMed ID: 38906154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host-Related Factors in the Interplay among Inflammation, Immunity and Dormancy in Breast Cancer Recurrence and Prognosis: An Overview for Clinicians.
    Ruggieri L; Moretti A; Berardi R; Cona MS; Dalu D; Villa C; Chizzoniti D; Piva S; Gambaro A; La Verde N
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process.
    Demicheli R; Miceli R; Moliterni A; Zambetti M; Hrushesky WJ; Retsky MW; Valagussa P; Bonadonna G
    Ann Oncol; 2005 Sep; 16(9):1449-57. PubMed ID: 15956037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant resistance and early-breast cancer: should we change treatment strategies?
    Galmarini CM; Tredan O; Galmarini FC
    Cancer Metastasis Rev; 2014 Mar; 33(1):271-83. PubMed ID: 24346157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence dynamics does not depend on the recurrence site.
    Demicheli R; Biganzoli E; Boracchi P; Greco M; Retsky MW
    Breast Cancer Res; 2008; 10(5):R83. PubMed ID: 18844974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does tumour dormancy offer a therapeutic target?
    Goss PE; Chambers AF
    Nat Rev Cancer; 2010 Dec; 10(12):871-7. PubMed ID: 21048784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour.
    Demicheli R; Bonadonna G; Hrushesky WJ; Retsky MW; Valagussa P
    Breast Cancer Res; 2004; 6(6):R689-96. PubMed ID: 15535851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient follow-up after treatment for early breast cancer: updated results after 5 years.
    Churn M; Kelly V
    Clin Oncol (R Coll Radiol); 2001; 13(3):187-94. PubMed ID: 11527293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Cardoso F; Fallowfield L; Costa A; Castiglione M; Senkus E;
    Ann Oncol; 2011 Sep; 22 Suppl 6():vi25-30. PubMed ID: 21908499
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma.
    Janni W; Gastroph S; Hepp F; Kentenich C; Rjosk D; Schindlbeck C; Dimpfl T; Sommer H; Braun S
    Cancer; 2000 May; 88(10):2252-9. PubMed ID: 10820346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The process of metastasisation for breast cancer.
    Engel J; Eckel R; Kerr J; Schmidt M; Fürstenberger G; Richter R; Sauer H; Senn HJ; Hölzel D
    Eur J Cancer; 2003 Aug; 39(12):1794-806. PubMed ID: 12888376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms governing metastatic dormancy in breast cancer.
    Dittmer J
    Semin Cancer Biol; 2017 Jun; 44():72-82. PubMed ID: 28344165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Late relapse of breast cancer after adjuvant chemotherapy].
    Lousberg L; Somja J; Collignon J; Gilles C; Jerusalem G
    Rev Med Liege; 2011; 66(5-6):306-10. PubMed ID: 21826967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.